Table of Content

1.Product Overview
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.Research Methodology
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validations
2.7.Assumptions and Limitations
3.Executive Summary
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.Voice of Customer
5.Global Drug Discovery Informatics Market Outlook
5.1.Market Size Forecast
5.1.1.By Value
5.2.Market Share Forecast
5.2.1.By Mode (In-house, Outsourced)
5.2.2.By Workflow (Discovery, Development)
5.2.3.By Services (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, Others)
5.2.4.By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others)
5.2.5.By Region
5.2.6.By Company (2023)
5.3.Market Map
6.North America Drug Discovery Informatics Market Outlook
6.1.Market Size Forecast
6.1.1.By Value
6.2.Market Share Forecast
6.2.1.ByMode
6.2.2.By Workflow
6.2.3.By Services
6.2.4.By End User
6.2.5.By Country
6.3.North America: Country Analysis
6.3.1.United States Drug Discovery Informatics Market Outlook
6.3.1.1.Market Size Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share Forecast
6.3.1.2.1.By Mode
6.3.1.2.2.By Workflow
6.3.1.2.3.By Services
6.3.1.2.4.By End User
6.3.2.Canada Drug Discovery Informatics Market Outlook
6.3.2.1.Market Size Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share Forecast
6.3.2.2.1.By Mode
6.3.2.2.2.By Workflow
6.3.2.2.3.By Services
6.3.2.2.4.By End User
6.3.3.Mexico Drug Discovery Informatics Market Outlook
6.3.3.1.Market Size Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share Forecast
6.3.3.2.1.By Mode
6.3.3.2.2.By Workflow
6.3.3.2.3.By Services
6.3.3.2.4.By End User
7.Europe Drug Discovery Informatics Market Outlook
7.1.Market Size Forecast
7.1.1.By Value
7.2.Market Share Forecast
7.2.1.By Mode
7.2.2.By Workflow
7.2.3.By Services
7.2.4.By End User
7.2.5.By Country
7.3.Europe: Country Analysis
7.3.1.Germany Drug Discovery Informatics Market Outlook
7.3.1.1.Market Size Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share Forecast
7.3.1.2.1.By Mode
7.3.1.2.2.By Workflow
7.3.1.2.3.By Services
7.3.1.2.4.By End User
7.3.2.United Kingdom Drug Discovery Informatics Market Outlook
7.3.2.1.Market Size Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share Forecast
7.3.2.2.1.By Mode
7.3.2.2.2.By Workflow
7.3.2.2.3.By Services
7.3.2.2.4.By End User
7.3.3.Italy Drug Discovery Informatics Market Outlook
7.3.3.1.Market Size Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share Forecasty
7.3.3.2.1.By Mode
7.3.3.2.2.By Workflow
7.3.3.2.3.By Services
7.3.3.2.4.By End User
7.3.4.France Drug Discovery Informatics Market Outlook
7.3.4.1.Market Size Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share Forecast
7.3.4.2.1.By Mode
7.3.4.2.2.By Workflow
7.3.4.2.3.By Services
7.3.4.2.4.By End User
7.3.5.Spain Drug Discovery Informatics Market Outlook
7.3.5.1.Market Size Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share Forecast
7.3.5.2.1.By Mode
7.3.5.2.2.By Workflow
7.3.5.2.3.By Services
7.3.5.2.4.By End User
8.Asia-Pacific Drug Discovery Informatics Market Outlook
8.1.Market Size Forecast
8.1.1.By Value
8.2.Market Share Forecast
8.2.1.By Mode
8.2.2.By Workflow
8.2.3.By Services
8.2.4.By End User
8.2.5.By Country
8.3.Asia-Pacific: Country Analysis
8.3.1.China Drug Discovery Informatics Market Outlook
8.3.1.1.Market Size Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share Forecast
8.3.1.2.1.By Mode
8.3.1.2.2.By Workflow
8.3.1.2.3.By Services
8.3.1.2.4.By End User
8.3.2.India Drug Discovery Informatics Market Outlook
8.3.2.1.Market Size Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share Forecast
8.3.2.2.1.By Mode
8.3.2.2.2.By Workflow
8.3.2.2.3.By Services
8.3.2.2.4.By End User
8.3.3.Japan Drug Discovery Informatics Market Outlook
8.3.3.1.Market Size Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share Forecast
8.3.3.2.1.By Mode
8.3.3.2.2.By Workflow
8.3.3.2.3.By Services
8.3.3.2.4.By End User
8.3.4.South Korea Drug Discovery Informatics Market Outlook
8.3.4.1.Market Size Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share Forecast
8.3.4.2.1.By Mode
8.3.4.2.2.By Workflow
8.3.4.2.3.By Services
8.3.4.2.4.By End User
8.3.5.Australia Drug Discovery Informatics Market Outlook
8.3.5.1.Market Size Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share Forecast
8.3.5.2.1.By Mode
8.3.5.2.2.By Workflow
8.3.5.2.3.By Services
8.3.5.2.4.By End User
9.South America Drug Discovery Informatics Market Outlook
9.1.Market Size Forecast
9.1.1.By Value
9.2.Market Share Forecast
9.2.1.By Mode
9.2.2.By Workflow
9.2.3.By Services
9.2.4.By End User
9.2.5.By Country
9.3.South America: Country Analysis
9.3.1.Brazil Drug Discovery Informatics Market Outlook
9.3.1.1.Market Size Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share Forecast
9.3.1.2.1.By Mode
9.3.1.2.2.By Workflow
9.3.1.2.3.By Services
9.3.1.2.4.By End User
9.3.2.Argentina Drug Discovery Informatics Market Outlook
9.3.2.1.Market Size Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share Forecast
9.3.2.2.1.By Mode
9.3.2.2.2.By Workflow
9.3.2.2.3.By Services
9.3.2.2.4.By End User
9.3.3.Colombia Drug Discovery Informatics Market Outlook
9.3.3.1.Market Size Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share Forecast
9.3.3.2.1.By Mode
9.3.3.2.2.By Workflow
9.3.3.2.3.By Services
9.3.3.2.4.By End User
10.Middle East and Africa Drug Discovery Informatics Market Outlook
10.1.Market Size Forecast
10.1.1.By Value
10.2.Market Share Forecast
10.2.1.By Mode
10.2.2.By Workflow
10.2.3.By Services
10.2.4.By End User
10.2.5.By Country
10.3.MEA: Country Analysis
10.3.1.South Africa Drug Discovery Informatics Market Outlook
10.3.1.1.Market Size Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share Forecast
10.3.1.2.1.By Mode
10.3.1.2.2.By Workflow
10.3.1.2.3.By Services
10.3.1.2.4.By End User
10.3.2.Saudi Arabia Drug Discovery Informatics Market Outlook
10.3.2.1.Market Size Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share Forecast
10.3.2.2.1.By Mode
10.3.2.2.2.By Workflow
10.3.2.2.3.By Services
10.3.2.2.4.By End User
10.3.3.UAE Drug Discovery Informatics Market Outlook
10.3.3.1.Market Size Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share Forecast
10.3.3.2.1.By Mode
10.3.3.2.2.By Workflow
10.3.3.2.3.By Services
10.3.3.2.4.By End User
11.Market Dynamics
11.1.Drivers
11.2.Challenges
12.Market Trends Developments
12.1.Recent Development
12.2.Mergers Acquisitions
12.3.Product Launches
13.Global Drug Discovery Informatics Market: SWOT Analysis
14.Porter?s Five Forces Analysis
14.1.Competition in the Industry
14.2.Potential of New Entrants
14.3.Power of Suppliers
14.4.Power of Customers
14.5.Threat of Substitute Products
15.Competitive Landscape
15.1.Dassault Systemes SE
15.1.1.Business Overview
15.1.2.Company Snapshot
15.1.3.Products Services
15.1.4.Financials (As Reported)
15.1.5.Recent Developments
15.1.6.Key Personnel Details
15.1.7.SWOT Analysis
15.2.IBM Corporation
15.3.Infosys Ltd.
15.4.Schr?dinger Inc.
15.5.Jubilant Life Sciences NV
15.6.Aragen Lifescience Ltd.
15.7.Charles River Laboratories Inc.
15.8.Thermo Fisher Scientific, Inc.
15.9.Clarivate Analytics LLC
15.10.PerkinElmer Inc.
16.Strategic Recommendations
17.About Us Disclaimer